Travere Therapeutics Presents Knowledge Reinforcing Scientific Advantage of FILSPARI ® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024 By Investing.com
Practically 60% of sufferers with IgAN within the SPARTAN Research achieved full…
Invitation to presentation of RaySearch’s interim report for the third quarter of 2024 By Investing.com
STOCKHOLM, Oct. 21, 2024 /PRNewswire/ -- Analysts, traders, and the media are…
Black Diamond Therapeutics to Host Webcast Presentation of Preliminary Part 2 BDTX-1535 Information in Sufferers With Recurrent EGFRm NSCLC By Investing.com
Webcast to be held Monday, September 23, at 8:00 a.m. ET CAMBRIDGE,…
